TITLE

Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors

AUTHOR(S)
Castellon, Xavier; Bogdanova, Vera
PUB. DATE
May 2013
SOURCE
Clinical Interventions in Aging;May2013, Vol. 8, p573
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Atherosclerosis is a leading cause of cardiovascular death due to the increasing prevalence of the disease and the impact of risk factors such as diabetes, obesity or smoking. Sudden cardiac death is the primary consequence of coronary artery disease in 50% of men and 64% of women. Currently the only available strategy to reduce mortality in the at-risk population is primary prevention; the target population must receive screening for atherosclerosis. The value of screening for subclinical atherosclerosis is still relevant, it has become standard clinical practice with the emergence of new noninvasive techniques (radio frequency [RF] measurement of intima-media thickness [RFQIMT] and arterial stiffness [RFQAS], and flow-mediated vasodilatation [FMV]), which have been used by our team since 2007 and are based on detection marker integrators which reflect the deleterious effect of risk factors on arterial remodeling before the onset of clinical events. These techniques allow the study of values according to age and diagnosis of the pathological value, the thickness of the intima media (RFQIMT), the speed of the pulse wave (RFQAS), and the degree of endothelial dysfunction (FMV). This screening is justified in asymptomatic patients with cardiovascular risk factors (hypertension, diabetes, obesity, dyslipidemia, and tobacco smoking). Studies conducted by RF coupled with two-dimensional echo since 2007 have led to a more detailed analysis of the state of the arterial wall. The various examinations allow an assessment of the degree of subclinical atherosclerosis and its impact on arterial remodeling and endothelial function. The use of noninvasive imaging in screening and early detection of subclinical atherosclerosis is reliable and reproducible and allows us to assess the susceptibility of our patients with risk factors and ensures better monitoring of atherosclerosis, thus reducing the occurrence of cardiovascular events in the long term.
ACCESSION #
88016202

 

Related Articles

  • Rising Burden of Obesity in Asia. Ramachandran, Ambady; Snehalatha, Chamukuttan // Journal of Obesity;2010, Vol. 2010, p1 

    Overweight and obesity have reached epidemic proportions in many Asian countries. These countries also face a grave burden of obesity-related disorders such as diabetes, hypertension, and cardiovascular diseases, which develop at a younger age than in Western populations. These disorders are...

  • "Hypertension and Diabetes". Masuo, Kazuko // Current Hypertension Reviews;Nov2011, Vol. 7 Issue 3, p125 

    No abstract available.

  • Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Williams, I.L.; Wheatcroft, S.B.; Shah, A.M.; Kearney, M.T. // International Journal of Obesity & Related Metabolic Disorders;Jun2002, Vol. 26 Issue 6, p754 

    Discusses the potential role of endothelial dysfunction in the excess cardiovascular risk of obese humans. Putative mechanisms underlying endothelial dysfunction; Potential targets for therapeutic intervention; General mechanisms of reduced nitric oxide bioavailability.

  • Key Global Literature. Fonseca, Vivian // Diabetes Care;Oct2004, Vol. 27 Issue 10, p2572 

    Presents an abstract of the article "The Atherosclerosis Risk in Communities Study Investigators: Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction," by C. D. Lee, A. R. Folsom, J. S. Pankow and F. L. Brancati.

  • Obesity: An overview on its current perspectives and treatment options. Nammi, Srinivas; Koka, Saisudha; Chinnala, Krishna M.; Boini, Krishna M. // Nutrition Journal;2004, Vol. 3, p3 

    Obesity is a multi-factorial disorder, which is often associated with many other significant diseases such as diabetes, hypertension and other cardiovascular diseases, osteoarthritis and certain cancers. The management of obesity will therefore require a comprehensive range of strategies...

  • Kids who often dine out at risk for health problems, group warns. Barrier, Brooke // Nation's Restaurant News;1/16/2006, Vol. 40 Issue 3, p16 

    The article reports on the initiative of food industry in providing more healthful menu items to children in order to avoid the risk to obesity, cardiovascular diseases (CVD) and diabetes. The Wausau SCHOOL, or the School Children Have early Onset Of Leading risk factors for CVD and diabetes,...

  • An indicator of subclinical cardiovascular disease in patients with primary osteoarthritis: epicardial fat thickness. Belen, Erdal; Ozgur Karaman; Caliskan, Gurkan; Atamaner, Oya; Aslan, Omer // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 6, p9491 

    Osteoarthritis (OA) is one of the most common chronic diseases seen in the elderly, and it is associated with increased cardiovascular morbidity and mortality. The cause of this association is not fully known. We aimed to investigate the relationship between epicardial fat and the presence and...

  • EXTREME OBESITY, SURGICAL WEIGHT LOSS, AND CARDIOVASCULAR HEALTH. BENOTTI, PETER N. // Bariatric Times;Aug2014, Vol. 11 Issue 8, p8 

    Severe obesity is a well-known risk factor for atherosclerosis and cardiovascular disease. Obesity is also a defining characteristic of the metabolic syndrome, a group of conditions associated with metabolic dysfunction and cardiovascular risk. The cardiovascular abnormalities that occur as a...

  • Opportunities for Pharmacotherapy at the Intersection of Metabolic Syndrome and Hemostasis. Michael, Laura F.; Rao, Veena; McCollam, Patrick; Kowala, Mark C.; Wetterau, John // Current Pharmaceutical Biotechnology;Sep2011, Vol. 12 Issue 9, p1463 

    Hemostatic balance is regulated by many factors that may become perturbed by cardio-metabolic abnormalities. Indeed, patients with multiple components of the metabolic syndrome have increased risk of atherosclerosis, hemostatic disorders and thrombotic events. This review focuses on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics